Koolau
Give me a museum and I'll fill it. (Picasso) Give me a forum ...
The whole healthcare cost issue is indeed thorny. I hope folks can resist one-size-fits-all approaches to fixing it. This isn't a "two-sides" issue (like labor and management). There are doctors, lawyers, drug companies, pharmacy benefit managers, insurance companies, politicians, activists, consumers, young people, old people, sick people, well people, US manufacturers, OUS manufacturers, NON PROFITS, etc. etc. etc which all have a stake in this. And YES, profit is a motive. I highlighted NON PROFITS because in my old town, there were ONLY non profit (or maybe you call them not-for-profit) hospitals. In any case, a study was done in which the services offered by these non profits were shown to be 60% HIGHER COST than at FOR PROFIT hospitals less than 100 miles away (same state). No, there was no "profit", but that was because the non profits found ways to disperse the extra funds. I thought this would turn into a huge scandal, but it never did because most folks have health insurance and don't really care what HC costs.
One thing I'm surprised no one has really picked up on is the statement in the article (which is even TRUER than one might expect) that the US is bearing the brunt of HC research. Virtually ALL other countries benefit more form US research than the US benefits from the limited HC research of outside countries. In the article, this disparity was couched as a reason that US costs are so high - profits are MADE and THEN poured back into research. True enough, but if the US didn't do it, it probably would not get done. We could solve the HC "problem" tomorrow with this simple solution: "We the Congress of the US have decided that the state of HC in the US (and the world) is now sufficient. It is hereby illegal to do any more HC research in the US." Problem solved (unless you are a HC consumer, of course). Perhaps a bit tongue-in-cheek, but, realistically, think of the HC benefits those of us on this forum (okay, us geezers over 60) have seen. When I was a kid, transplants, bypasses, most current drug therapies, DID NOT EXIST. Now, they are all but routine. Expensive - but routine. Should we go back? Should we stop research? I think not. This is ONE situation in which cost "inflation" needs to take into account the "quality" and "alternative". Quick example: Does anyone know a single person who, in the past 20 years has had surgery for a stomach ulcer? Probably not, because the 3 generations of ulcer drug therapies have all but eliminated ulcers. Don't know the cost savings, but the pain relief alone has probably been worth the drug costs. If you knew anyone with an ulcer (25 years ago) I think you will know what I'm talking about.
I realize there are a lot more issues here than I've pointed out and I really am not taking a "side" (too many sides to figure out which one to be "on"). My contention is that if we let our Federal gummint "solve" it for us we may not like the lack of control we have over the services available to us AND, I submit, we STILL won't like the cost. Naturally, as a non-expert, I caution that YMMV.
One thing I'm surprised no one has really picked up on is the statement in the article (which is even TRUER than one might expect) that the US is bearing the brunt of HC research. Virtually ALL other countries benefit more form US research than the US benefits from the limited HC research of outside countries. In the article, this disparity was couched as a reason that US costs are so high - profits are MADE and THEN poured back into research. True enough, but if the US didn't do it, it probably would not get done. We could solve the HC "problem" tomorrow with this simple solution: "We the Congress of the US have decided that the state of HC in the US (and the world) is now sufficient. It is hereby illegal to do any more HC research in the US." Problem solved (unless you are a HC consumer, of course). Perhaps a bit tongue-in-cheek, but, realistically, think of the HC benefits those of us on this forum (okay, us geezers over 60) have seen. When I was a kid, transplants, bypasses, most current drug therapies, DID NOT EXIST. Now, they are all but routine. Expensive - but routine. Should we go back? Should we stop research? I think not. This is ONE situation in which cost "inflation" needs to take into account the "quality" and "alternative". Quick example: Does anyone know a single person who, in the past 20 years has had surgery for a stomach ulcer? Probably not, because the 3 generations of ulcer drug therapies have all but eliminated ulcers. Don't know the cost savings, but the pain relief alone has probably been worth the drug costs. If you knew anyone with an ulcer (25 years ago) I think you will know what I'm talking about.
I realize there are a lot more issues here than I've pointed out and I really am not taking a "side" (too many sides to figure out which one to be "on"). My contention is that if we let our Federal gummint "solve" it for us we may not like the lack of control we have over the services available to us AND, I submit, we STILL won't like the cost. Naturally, as a non-expert, I caution that YMMV.